| BCBS Federal Medical & Drug | 2.04.93 Genetic Cancer Susceptibility Panels Using Next Generation Sequencing | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.97 Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.107 Carrier Screening for Genetic Diseases | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.108 Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.115 Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.116 Invasive Prenatal (Fetal) Diagnostic Testing | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.117 Genetic Testing for Mitochondrial Disorders | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.122 Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.126 Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1) | 2025-12-01 |
| BCBS Federal Medical & Drug | 2.04.139 Genetic Testing for Heterozygous Familial Hypercholesterolemia | 2025-12-01 |